$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] La dysfonction érectile du diabétique
Erectile dysfunction in diabetic patients

Sexologies : European journal of sexology and sexual health = Revue européenne de sexologie et de santé sexuelle, v.27 no.1, 2018년, pp.53 - 58  

Colson, M.H. (Service d’immuno-hé) ,  Cuzin, B. (matologie clinique (C.I.S.I.H), hô) ,  Faix, A. (pital Sainte-Marguerite, 13009 Marseille, France) ,  Grellet, L. (Groupement hospitalier É) ,  Huyghes, E. (douard-Herriot, 69437 Lyon cedex, France)

Abstract AI-Helper 아이콘AI-Helper

Summary It is estimated that erectile dysfunction (ED) affects globally and on average, one man in five; this figure is 4.5 times higher in diabetic patients, for whom the onset occurs on average 10 to 15 years earlier. ED has a highly semeiological value in diabetic patients, as its onset marks a ...

Abstract

Résumé Alors que la dysfonction érectile (DE) touche en moyenne un homme sur cinq dans le monde, on estime habituellement qu’elle est 4,5 fois plus fréquente chez le diabétique, et qu’elle survient chez lui en moyenne 10 à 15 ans plus tôt. La DE revêt chez le diabétique une valeur hautement séméiologique car elle marque, par son installation, une étape significative de l’évolution du diabète et de son retentissement viscéral. Elle apparaît aujourd’hui comme l’indicateur le plus fiable des complications microangiopathiques du diabète et le marqueur privilégié d’une possible ischémie silencieuse. La dysfonction érectile, lors de son apparition, s’accompagne chez tous les hommes de perturbations émotionnelles et relationnelles majeures. Chez le diabétique, les conséquences en sont encore plus marquées et responsables d’une altération importante de tous les domaines de la qualité de vie, ainsi que d’une moindre tolérance aux contraintes du diabète, pouvant en compromettre l’observance thérapeutique et l’équilibre métabolique. Les médecins généralistes ont encore beaucoup de mal à prendre en considération la DE du diabétique et à la dépister systématiquement, tout autant qu’à la prendre en charge. Il est cependant possible de faire évoluer nos pratiques pour mieux intégrer la prise en compte de la pathologie sexuelle chez nos patients, tout particulièrement diabétiques, d’aller au-devant de leur demande et de proposer des solutions thérapeutiques efficaces adaptées à leur attente.

Keyword

참고문헌 (51)

  1. Diabetes Res Clin Pract Abdullah 89 309 2010 10.1016/j.diabres.2010.04.012 The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies 

  2. Diabetes Care Anderson 24 6 1069 2001 10.2337/diacare.24.6.1069 The prevalence of comorbid depression in adults with diabetes: a meta-analysis 

  3. Nat Rev Urol Aversa 12 11 641 2015 10.1038/nrurol.2015.238 The practical management of testosterone deficiency in men 

  4. Diabetes Care Bacon 25 1458 2002 10.2337/diacare.25.8.1458 Association of type and duration of diabetes with erectile dysfunction in a large cohort of men 

  5. Diabetes Care Bax 21 7 1159 1998 10.2337/diacare.21.7.1159 Rigiscan evaluation of specific nervous impairment in patients with diabetes and erectile disorders 

  6. Aging Male Boyanov 6 1 1 2003 10.1080/tam.6.1.1.7 Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency 

  7. J Sex Med Brock 13 5 860 2016 10.1016/j.jsxm.2016.02.171 Efficacy of continuous dosing of tadalafil once daily vs tadalafil on demand in clinical subgroups of men with erectile dysfunction: a descriptive comparison using the integrated tadalafil databases 

  8. J Urol Burke 177 4 1438 2007 10.1016/j.juro.2006.11.059 Diabetes and sexual dysfunction: results from the Olmsted County study of urinary symptoms and health status among men 

  9. J Sex Med Buvat 7 4 Pt 2 1627 2010 10.1111/j.1743-6109.2010.01780.x Endocrine aspects of male sexual dysfunctions 

  10. J Clin Invest Calver 90 2548 1992 10.1172/JCI116149 Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes 

  11. Diabet Med Cheyne 21 3 230 2004 10.1111/j.1464-5491.2004.01154.x Influence of alcohol on cognitive performance during mild hypoglycaemia; implications for Type 1 diabetes 

  12. Eur Urol Corona 46 2 222 2004 10.1016/j.eururo.2004.03.010 Organic, relational and psychological factors in erectile dysfunction in men with diabetes mellitus 

  13. Diabetes Care De Berardis 25 2 284 2002 10.2337/diacare.25.2.284 A: erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked 

  14. J Urol De Berardis 169 1422 2003 10.1097/01.ju.0000053241.06172.95 Identifying patients with type 2 diabetes with a higher likelihood of erectile dysfunction: the role of the interaction between clinical and psychological factors 

  15. Diabetes Care De Berardis 28 2637 2005 10.2337/diacare.28.11.2637 Longitudinal assessment of quality of life in patients with type 2 diabetes and self-reported erectile dysfunction 

  16. Psychosom Med De Groot 63 619 2001 10.1097/00006842-200107000-00015 Association of depression and diabetes complications: a meta-analysis 

  17. J Clin Endocrinol Metab Dhindsa 89 11 5462 2004 10.1210/jc.2004-0804 Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes 

  18. Int J Clin Pract Eardley 61 9 1446 2007 10.1111/j.1742-1241.2007.01460.x The multinational men's attitudes to life events and sexuality study: the influence of diabetes on self-reported erectile function, attitudes and treatment-seeking patterns in men with erectile dysfunction 

  19. Clin Sci Elliott 85 687 1993 10.1042/cs0850687 Inhibition of nitric oxide synthesis in forearm vasculature of insulin dependent patients: blunted vasoconstriction in patients with microalbuminuria 

  20. Diabetes Care Fedele 21 1973 1998 10.2337/diacare.21.11.1973 Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici 

  21. Int J Epidemiol Fedele 29 524 2000 10.1093/intjepid/29.3.524 Erectile dysfunction in type 1 and type 2 diabetics in Italy 

  22. J Urol Feldman 151 54 1994 10.1016/S0022-5347(17)34871-1 Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study 

  23. Diabetes Care Ford 28 1769 2005 10.2337/diacare.28.7.1769 Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence 

  24. J Am Coll Cardiol Gazzaruso 51 2040 2008 10.1016/j.jacc.2007.10.069 Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease a potential protective role for statins and 5-phosphodiesterase inhibitors 

  25. Arch Ital Urol Androl Gentile 88 1 1 2016 10.4081/aiua.2016.1.1 Patient's satisfaction after 2-piece inflatable penile prosthesis implantation: an Italian multicentric study 

  26. Urology Giuliano 64 1196 2004 10.1016/j.urology.2004.08.059 Prevalence of erectile dysfunction among 7,689 patients with diabetes or hypertension, or both 

  27. Int J Impot Res Giugliano 22 3 204 2010 10.1038/ijir.2010.1 Determinants of erectile dysfunction in type 2 diabetes 

  28. Psychosom Med Golden 69 529 2007 10.1097/PSY.0b013e3180f61c5c Depression and type 2 diabetes mellitus: the multiethnic study of atherosclerosis 

  29. Diabetes Metab Guillausseau 29 1 79 2003 10.1016/S1262-3636(07)70011-3 Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice 

  30. J Sex Med Hackett 13 6 887 2016 10.1016/j.jsxm.2016.01.023 Coronary heart disease, diabetes, and sexuality in men 

  31. Psychosom Med Hall 70 7 837 2008 10.1097/PSY.0b013e31817bb8e5 Anxious temperament and disease progression at diagnosis: the case of type 2 diabetes 

  32. Int J Impot Res Heaton 13 6 317 2001 10.1038/sj.ijir.3900760 Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men 

  33. Jardin 1999 Recommandations du comité scientifique international sur evaluation et traitement de la dysfonction erectile. First international consultation on erectile dysfunction, Paris 

  34. J Urol Johannes 163 460 2000 10.1016/S0022-5347(05)67900-1 Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts male aging study 

  35. Diabetologia Kacerovsky-Bielesz 52 5 781 2009 10.1007/s00125-009-1318-7 Sex-related psychological effects on metabolic control in type 2 diabetes mellitus 

  36. Diabetes Care Kalter-Leibovici 28 1739 2005 10.2337/diacare.28.7.1739 Clinical, socioeconomic, and lifestyle parameters associated with erectile dysfunction among diabetic men 

  37. JAMA Psychiatry Katon 72 6 612 2015 10.1001/jamapsychiatry.2015.0082 Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study 

  38. J Urol Lowentritt 171 231 2004 10.1016/S0022-5347(18)38123-0 The effect of erectile dysfunction on patient medication compliance 

  39. J Am Coll Cardiol Ma 51 2045 2008 10.1016/j.jacc.2008.02.051 Erectile dysfunction predicts coronary heart disease in Type 2 diabetes 

  40. J Sex Med Malavige 6 5 1232 2009 10.1111/j.1743-6109.2008.01168.x Erectile dysfunction in diabetes mellitus 

  41. Diabetes Educ McKellar 30 3 485 2004 10.1177/014572170403000320 Depression increases diabetes symptoms by complicating patients’ self-care adherence 

  42. Acta Diabetol Montorsi 31 1 1 1994 10.1007/BF00580752 Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence 

  43. Diabetes Care Penson 26 1093 2003 10.2337/diacare.26.4.1093 Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the exploratory comprehensive evaluation of erectile dysfunction (ExCEED) database 

  44. J Sex Med Rooney 6 2 520 2009 10.1111/j.1743-6109.2008.01118.x Long-term, multicenter study of the safety and efficacy of topical alprostadil cream in male patients with erectile dysfunction 

  45. Int J Impot Res Schwartz 22 77 2009 10.1038/ijir.2009.59 The endothelial cell in health and disease: its function, dysfunction, measurement and therapy 

  46. Diabetes Soro-Paavonen 57 9 2461 2008 10.2337/db07-1808 Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes 

  47. Eur Urol Tsai 38 2 177 2000 10.1159/000020277 Safety and efficacy of alprostadil sterile powder (S. Po., CAVERJECT) in diabetic patients with erectile dysfunction 

  48. Asian J Androl Vlachopoulos 17 1 17 2015 10.4103/1008-682X.143250 Biomarkers, erectile dysfunction, and cardiovascular risk prediction: the latest of an evolving concept 

  49. Diabetes Care Wild 27 5 1047 2004 10.2337/diacare.27.5.1047 Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 

  50. Circulation Wilson 112 3066 2005 10.1161/CIRCULATIONAHA.105.539528 Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus 

  51. Diabetes Res Clin Pract Zheng 71 313 2006 10.1016/j.diabres.2005.07.011 Predictors for erectile dysfunction among diabetics 

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로